RxDoctor Payments Data

Sean Hart

Family · Tiffin, OHNPI 1679187926

Payments from drug & device makers

$606in general payments, 2019–2025

Across 30 payments — averaging $20.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$122
  • Teva Pharmaceuticals USA, Inc.$91
  • Procept Biorobotics Corporation$87
  • Ferring Pharmaceuticals Inc.$59
  • UCB, Inc.$48
  • Astellas Pharma US Inc$34
  • plus $165 from 9 others

What the payments were for

  • Food & beverage$52186%
  • Education$8514%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$606 in reported general payments places this provider in the 60th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$13,674
Medicare patients
152
Services billed
248

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron33$11,856
GemtesaVibegron21$10,239
Tamsulosin Hcl212$2,674
Fosfomycin Tromethamine14$1,168
Tolterodine Tartrate ErTolterodine Tartrate11$1,151
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst97$1,135
Trimethoprim20$1,005
Cefdinir82$891
Potassium Citrate ErPotassium Citrate11$702
Finasteride32$282
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim98$275
Alfuzosin Hcl ErAlfuzosin Hcl19$263
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$197
Fluconazole19$141
Ciprofloxacin Hcl38$127

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$34$11,85633 claims
Sumitomo Pharma America, Inc.Gemtesa$22$10,23921 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,812 family providers in Ohio.

Other family in Tiffin

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →